Lupin, a leading pharmaceutical company, stated that it has gotten approval from the US Food and medicine Administration to offer a generic medicine to treat migraines and hypertension. The Mumbai-based business has gained approval from the US...
Stada and Alvotech announced that the European Commission has granted marketing permission for Uzpruvo (AVT04), a biosimilar candidate to Stelara (ustekinumab). The unified marketing authorization for Europe's first ustekinumab biosimilar is valid...
The start of GenePHIT (Gene Phosphatase Inhibition Therapy), a phase II trial of AB-1002 (also known as NAN-101) for the treatment of congestive heart failure (CHF), has been announced by Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a...
The sales of gout therapies in the seven major markets (7MM: the US, 5EU, and Japan) are expected to grow at a compound annual growth rate (CAGR) of 8.8 percent from $4.6 billion in 2022 to $10.8 billion in 2032, in line with rising disease...
Isomorphic Labs, a digital biology company with a mission to redefine drug discovery through the power of artificial intelligence, has announced a strategic research collaboration with Eli Lilly, an American pharmaceutical company headquartered in...
The innovative systems and solutions provider Gerresheimer, a global partner to the pharmaceutical, biotech, and cosmetics industries, and Aptar Digital Health, a leader in software as a medical device (SaMD), digital patient support programs...
The supplemental Biologics License Application (sBLA), filed on behalf of Pfizer Inc. and Genmab A/S, aims to convert the accelerated approval of Tivdak (tisotumab vedotin-tftv) to full approval for the treatment of patients with recurrent or...
Akumentis Healthcare Limited has launched Clasepi to combat epilepsy-related issues. Clasepi, a DCGI-approved prescription cannabidiol (CBD), is specifically developed to treat seizures caused by Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or...
At the Trade Policy Forum (TPF) meeting, India will strongly demand that the American health regulator expedite its USFDA inspections or audits of domestic pharmaceutical firms, lift the export ban on wild caught shrimp, and raise the issue of...
Transgen announced that they have signed an additional development cooperation agreement for personalized interventions. neoantigen cancer vaccine TG4050. TG4050 is currently being evaluated in a randomized multicenter phase I trial as a single...
, CDSCO.jpg)
